Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M20.2Revenue (TTM) $M4.3Net Margin (%)-485.0Altman Z-Score-32.1
Enterprise Value $M5.6EPS (TTM) $-4.0Operating Margin %-536.6Piotroski F-Score2
P/E(ttm)--Beneish M-Score-5.7Pre-tax Margin (%)-484.7Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio1.7Cash flow > EarningsY
Price/Sales1.85-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-100.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-605.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M9.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ONTX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ONTX is held by these investors:



ONTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bienen Henry SDirector 2017-04-26Buy3,810$2.11.43view
Guerin Mark PatrickCFO 2017-04-26Buy1,429$2.11.43view
MARINO JAMES JDirector 2017-04-26Buy11,906$2.11.43view
Reddy E PremkumarDirector 2017-04-26Buy119,048$2.11.43view
Kumar RameshPresident and CEO 2017-04-26Buy23,810$2.11.43view
Michael & Jane Hoffman 2013 De10% Owner 2014-02-21Buy14,348$84.7-97.49view
Hoffman Michael BDirector, 10% Owner 2014-02-21Buy14,348$84.7-97.49view
Kumar RameshPresident and CEO 2014-02-10Sell3,354$150.7-98.59view
Kumar RameshPresident and CEO 2014-02-03Sell6,000$150.5-98.58view
Hoffman Michael BDirector, 10% Owner 2014-01-27Buy5,730$119.2-98.21view

Press Releases about ONTX :

Quarterly/Annual Reports about ONTX:

    News about ONTX:

    Articles On GuruFocus.com
    Onconova Therapeutics to Present at the BIO International Convention Jun 13 2017 
    Onconova Therapeutics Announces Positive Phase 2 Data in Rigosertib Treated Patients with Second-lin Jun 05 2017 
    Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2017 Financial Results May 04 2017 
    Onconova to Present Rigosertib Clinical Data at the 14th International Symposium on Myelodysplastic May 01 2017 
    Onconova Therapeutics Announces Closing of Public Offering of Common Stock Apr 26 2017 
    Onconova Therapeutics, Inc. to Present at PIONEERS 2017 Presented by Joseph Gunnar & Co., LLC Apr 26 2017 
    Onconova Therapeutics Announces Pricing of Public Offering of Common Stock Apr 21 2017 
    Onconova Therapeutics Announces Proposed Public Offering of Common Stock Apr 20 2017 
    Onconova Therapeutics Announces Positive Preclinical Data for Third-Generation Oral CDK4/6 + ARK5 In Apr 04 2017 
    Onconova Therapeutics, Inc. Reports Recent Business Highlights and Year-end 2016 Financial Results Mar 27 2017 

    More From Other Websites
    Onconova Therapeutics Presents Rigosertib Data at the 22nd Congress of the European Hematology... Jun 26 2017
    Onconova Therapeutics, Inc. :ONTX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Jun 16 2017
    Onconova Therapeutics to Present at the BIO International Convention Jun 13 2017
    UPDATE: Onconova Therapeutics stock surges 7% on positive mid-stage clinical trial results Jun 05 2017
    Onconova Therapeutics Announces Positive Phase 2 Data in Rigosertib Treated Patients with... Jun 05 2017
    Onconova Announces Multiple Presentations at the 22nd Congress of the European Hematology... May 22 2017
    Edited Transcript of ONTX earnings conference call or presentation 15-May-17 1:00pm GMT May 19 2017
    Onconova Therapeutics to Present a Poster Session Relating to Intravenous Rigosertib at the 2017... May 18 2017
    Onconova Therapeutics, Inc. Reports Recent Business Highlights and First Quarter 2017 Financial... May 15 2017
    Investor Network: Onconova Therapeutics Inc. to Host Earnings Call May 15 2017
    Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2017 Financial Results May 04 2017
    Onconova to Present Rigosertib Clinical Data at the 14th International Symposium on Myelodysplastic... May 01 2017
    Onconova Therapeutics Announces Closing of Public Offering of Common Stock Apr 26 2017
    Onconova Therapeutics, Inc. to Present at PIONEERS 2017 Presented by Joseph Gunnar & Co., LLC Apr 26 2017
    Onconova Therapeutics stock drops 12% after pricing stock offering Apr 21 2017
    Onconova Therapeutics Announces Pricing of Public Offering of Common Stock Apr 21 2017
    Onconova Therapeutics Announces Proposed Public Offering of Common Stock Apr 20 2017
    Company News for April 05, 2017 Apr 05 2017
    Onconova Therapeutics and Pluristem Therapeutics Surge as Candidate Drugs Move Closer to Final... Apr 05 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat

    {{numOfNotice}}